scholarly journals A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer

Oral Oncology ◽  
2015 ◽  
Vol 51 (4) ◽  
pp. 383-388 ◽  
Author(s):  
Antonio Jimeno ◽  
Julie E. Bauman ◽  
Charles Weissman ◽  
Douglas Adkins ◽  
Ian Schnadig ◽  
...  
Cancer ◽  
2010 ◽  
Vol 117 (4) ◽  
pp. 795-801 ◽  
Author(s):  
Matthew G. Fury ◽  
Sofia Haque ◽  
Hilda Stambuk ◽  
Ronglai Shen ◽  
Diane Carlson ◽  
...  

2011 ◽  
Vol 227 (2) ◽  
pp. 467-473 ◽  
Author(s):  
Santanu Dasgupta ◽  
Rupesh Dash ◽  
Swadesh K. Das ◽  
Devanand Sarkar ◽  
Paul B. Fisher

2013 ◽  
Vol 34 (8) ◽  
pp. 1632-1636 ◽  
Author(s):  
M. McDermott ◽  
M. Hughes ◽  
T. Rath ◽  
J.T. Johnson ◽  
D.E. Heron ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document